(NasdaqGM:BBOT), SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) — BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in December. Details of the company's participation are as follows: Piper Sandler 37th Annual Healthcare […]

(NYSE:PINE), WINTER PARK, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) — Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that its Board of Directors has authorized, and the Company has declared, a quarterly cash dividend of $0.285 per share of common stock for the fourth quarter of 2025 (the “Common Stock Cash Dividend”).

(NYSE:CTO), WINTER PARK, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) announced today that its Board of Directors has authorized, and the Company has declared, a quarterly cash dividend of $0.38 per share of common stock for the fourth quarter of 2025 (the “Common Stock Cash

Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine GlobeNewswire November 18, 2025 IRVINE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced preliminary results from an investigator-initiated trial conducted

PDF Solutions Announces Speakers and Agenda for its Users Conference and Analyst Day GlobeNewswire November 18, 2025 SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) — On December 3rd and 4th, 2025, PDF Solutions will host its Users Conference and Analyst Day in Santa Clara, CA. The semiconductor industry is experiencing accelerated innovation; demand has

Neurona Therapeutics Appoints Dr. Eduardo Dunayevich as Chief Medical Officer GlobeNewswire November 18, 2025 SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) — Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment of Eduardo Dunayevich, M.D., as Chief Medical Officer. “We are excited

MYR Group Inc. to Attend Oppenheimer Winter Industrial Virtual Summit in December GlobeNewswire November 18, 2025 THORNTON, Colo., Nov. 18, 2025 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced

Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference GlobeNewswire November 18, 2025 MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Piper Sandler 37th

BBOT to Participate in Upcoming December Investor Healthcare Conferences GlobeNewswire November 18, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) — BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in December. Details

Star Bulk Carriers Corp. Reports Financial Results for the Third Quarter of 2025, and Declares Quarterly Dividend of $0.11 Per Share GlobeNewswire November 18, 2025 ATHENS, Greece, Nov. 18, 2025 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq: SBLK), a global shipping company focusing on the transportation of dry bulk